Analyst interview | Investment Companies
Q&A on Fidelity Special Values (FSV): Consistently outperforming for over a decade
Fidelity Special Values (FSV) is the topic of conversation when Dr Brian Moretta, Analyst at Hardman & Co joins DirectorsTalk Interviews.
Brian takes us through his note entitled 'Making a case study for outperformance'. He explains the investment process, how the Fidelity structure supports it and how the two case studies were selected.
Fidelity Special Values plc aims to seek out underappreciated companies primarily listed in the UK and is an actively managed contrarian Investment Trust that thrives on volatility and uncertainty.
If you are interested in meeting the company, you can register your interest here
| To contact us: Hardman & Co London EC2R 8AE Follow us on Twitter @HardmanandCo | Analyst: Brian Moretta
|
|
Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.
About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
